D-0038-2025 Class II Ongoing
FDA drug recall D-0038-2025 was initiated by VIONA PHARMACEUTICALS INC on Oct 29, 2024 and is designated Class II. Reason for recall: Crystallization The recall status is ongoing. Affected quantity: 6048 pumps.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 13, 2024
- Initiation Date
- Oct 29, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6048 pumps
Product description
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.
Reason for recall
Crystallization
Distribution pattern
USA Nationwide
Code information
Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0038-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026